Monitoring Local Tissue Oxygen Changes Using the Wireless Lumee Oxygen Platform in Correlation to TcPO2
a study on Peripheral Arterial Disease
- for people ages 18 years and up (full criteria)
- at San Francisco, California and other locations
- study startedestimated completion
- Principal Investigator
- by Shant Vartanian, MDJames C Iannuzzi, MDMichael S Conte, MD
Peripheral Artery Disease, Peripheral Arterial Disease, Tissue Oxygen Monitoring, TcPO2, Wireless Lumee Oxygen Platform
Lead Scientists at UCSF
- Shant Vartanian, MD
The enhanced longevity of patients living with chronic HIV infection has resulted in an increasing burden of chronic diseases, and while there is growing evidence that HIV infected patients at risk for coronary artery disease at rates of up to two fold higher than the uninfected, the significance of chronic HIV infection in the peripheral vasculature is largely unknown.
- James C Iannuzzi, MD
James C. Iannuzzi, M.D., MPH is a vascular surgeon in the Division of Vascular and Endovascular Surgery at UCSF. Dr. Iannuzzi earned his MD at Icahn School of Medicine Mount Sinai, and thereafter completed a general surgery residency at University of Rochester Medical Center where he also earned an MPH. His thesis was on the pleiotropic effects of statins on perioperative outcomes.
- Michael S Conte, MD
Professor, Surgery, School of Medicine. Authored (or co-authored) 280 research publications
- accepting new patients
- Start Date
- Completion Date
- Profusa, Inc.
- Study Type
- Expecting 53 study participants
- Last Updated